¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cellular immunity deficiency syndrome"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • dysarthria clumsy hand syndrome
    Á¶À½Àå¾Ö¼­Å÷¼ÕÁõÈıº
  • delayed sleep phase syndrome
    ¼ö¸éÀ§»óÁö¿¬ÁõÈıº
  • Dandy-Walker syndrome
    ´íµð-¿öÄ¿ÁõÈıº
  • dead-in-bed syndrome
    ħ´ë»ç¸ÁÁõÈıº
  • dialysis disequilibrium syndrome
    Åõ¼®ºÒ±ÕÇüÁõÈıº
  • Diamond-Blackfan syndrome
    ´ÙÀ̾Ƹóµå-ºí·¢ÆÇÁõÈıº
  • Down syndrome
    ´Ù¿îÁõÈıº
  • exfoliation syndrome
    ¹ÚÅ»ÁõÈıº
  • ectrodactyly-ectodermal dysplasia clefting syndrome
    °áÁö¿Ü¹è¿±Çü¼ºÀ̻󰥸²ÁõÈıº
  • extrapyramidal syndrome
    ÇǶó¹Ìµå¹Ù±ù±æÁõÈıº, Ãßü¿Ü·ÎÁõÈıº
  • empty nest syndrome
    ºóµÕÁöÁõÈıº
  • empty sella syndrome
    ºó¾ÈÀåÁõÈıº
  • entrapment syndrome
    Æ÷ÂøÁõÈıº
  • eosinophilia-myalgia syndrome
    È£»ê±¸Áõ°¡±Ù(À°)ÅëÁõÁõÈıº
  • epidermal nevus syndrome
    Ç¥ÇǸð¹ÝÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • clinical syndrome
    ÀÓ»óÁõÈıº
  • clumsy child syndrome
    µÐÇѾƵ¿ÁõÈıº
  • clumsy hand syndrome
    ¼­Å÷¼ÕÁõÈıº
  • co-contraction syndrome
    µ¿½Ã¼öÃàÁõÈıº
  • combined immunodeficiency syndrome
    º¹Çո鿪°áÇÌÁõÈıº
  • compartment syndrome
    ±¸È¹ÁõÈıº
  • complex regional pain syndrome
    º¹ÇÕ±¹¼Òµ¿ÅëÁõÈıº
  • compression syndrome
    ¾Ð¹ÚÁõÈıº
  • concentration camp syndrome
    ¼ö¿ë¼ÒÁõÈıº
  • congenital constriction ring syndrome
    ¼±ÃµÇùÂø°í¸®ÁõÈıº
  • cor pulmonale syndrome
    Æó½ÉÀåÁõÈıº, ÇãÆÄ½ÉÀåÁõÈıº
  • cord compression syndrome
    ô¼ö¾Ð¹ÚÁõÈıº
  • cranial nerve syndrome
    ³ú½Å°æÁõÈıº
  • craniofacial syndrome
    ¸Ó¸®¾ó±¼ÁõÈıº
  • cri du chat syndrome
    (¢¡cat¡¯s cry) °í¾çÀÌ¿ïÀ½ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • Charlins syndrome
    »þ¸¦·©ÁõÈıº.
  • Chauffard-Still syndrome
    ¼îÆÄ¸£-½ºÆ¿ÁõÈıº.
  • Chediak-Higashi syndrome
    ¼¼µð¾ÆÅ©-È÷°¡½Ã ÁõÈıº
  • Chediak-Higashi syndrome
    ¼¼µð¾ÆÅ©-È÷°¡½ÃÁõÈıº.
  • Chilaiditis syndrome
    ų¶óÀ̵ðƼÁõÈıº.
  • Chronic fatigue syndrome
    ¸¸¼ºÇÇ·Î ÁõÈıº
  • Churg-Strauss syndrome
    Ãʱ×-½ºÅä¶ó¿ì½º ÁõÈıº
  • Cockayne syndrome
    ÄÚÄÉÀÎ ÁõÈıº(~ ñøý¦ÏØ)
  • Cockaynes syndrome
    ÄÚÄÉÀÎ ÁõÈıº
  • Coffin-Lowry syndrome
    ÄÚÇÉ-·Î¸® ÁõÈıº
  • Coffin-Siris syndrome
    ÄÚÇÉ-½Ã¸®½º ÁõÈıº
  • Cogan-Reese syndrome
    ÄÚ°£-¸®½ºÁõÈıº
  • Conn syndrome
    ÄÜÁõÈıº
  • Conns syndrome
    ÄÜÁõÈıº.
  • Conradi syndrome => chondrodysplasia calcificans congenita
    ¼±Ãµ¼º Ä®½·È­ ¿¬°ñ ÀÌÇü¼º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • racial immunity
    ¹ÎÁ·¸é¿ª(ÊÙËÎËç).
  • relative immunity
    »ó´ë¸é¿ª(¡­Øóæ¹).
  • residual immunity
    ÀÜ¿©¸é¿ª(íÑæ®Øóæ¹).
  • sperm immunity
    Á¤Àڸ鿪
  • tissue immunity
    Á¶Á÷¸é¿ª(¡­Øóæ¹)
  • transplacental immunity
    °æÅ¹ݸ鿪(¡­Øóæ¹).
  • transplacental passive immunity
    °æÅ¹ݼöµ¿¸é¿ª(¡­áôÔÑØóæ¹).
  • transplantation immunity
    À̽ĸ鿪(¡­Øóæ¹)
  • transplantation immunity
    À̽ĸ鿪(¡­Øóæ¹).
  • tumor immunity
    Á¾¾ç¸é¿ª
  • tumor immunity,antibody-based therapy
    Ç×ü¿¡ ÀǰÅÇÑ Ä¡·á
  • tumor immunity,gene therapy and
    À¯ÀüÀÚ Ä¡·á¿Í ¡­
  • angry back syndrome => excited skin syndrome
  • syndrome, Steiners [=curtius syndrome, facial hem
    ¾È¸é¹Ý(ÂÊ)ºñ´ëÁõ
  • acid lipase deficiency
    »ê¼º ¸®ÆÄÁ¦ °áÇÌÁõ(ß«àõ¡­ÌÀù¹ñø)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
APCD acquired prothrombin complex deficiency [syndrome]; adult polycystic kidney disease
ED early-decision [applicant]; early differentiation; ectodermal dysplasia; ectopic depolarization; eff...
GRANDDAD growth delay-aged facies-normal development-deficiency of subcutaneous fat [syndrome]
IFDS isolated follicle-stimulating hormone deficiency syndrome
MEDAC multiple endocrine deficiency, Addison's disease, and candidiasis [syndrome]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
EFAD Essential fatty acid deficiency
GH-D GH deficiency
G6PD Glucose-6-Phosphate dehydrogenase deficiency
GKD Glycerol kinase deficiency
GHD Growth Hormone Deficiency
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • B-K mole syndrome
    B-K ¸ð¹Ý ÁõÈıº
  • Barters syndrome
    ¹ÙÅÍ ÁõÈıº
  • basal ganglion calcification syndrome
    ±âÀú ½Å°æÀý ¼®È¸È­ ÁõÈıº
  • battered child syndrome
    ÇÇÇÐ´ë¾Æ ÁõÈıº, ¾Æµ¿ Çдë ÁõÈıº, ¼Ò¾Æ Çдë ÁõÈıº
    ¾Æµ¿ÀÇ »À ¹× ¿¬ºÎ Á¶Á÷¿¡ ´Ù¼öÀÇ ¿Ü»ó¼º º´º¯À» ³ªÅ¸³»´Â °ÍÀ¸·Î¼­ Á¾Á¾ °æ¸·ÇÏ Ç÷Á¾À» ¼ö¹ÝÇÑ´Ù. ÀÌ·± º´º¯Àº º¸Åë ¼ºÀÎÀÇ °íÀÇÀûÀÎ °¡ÇØ¿¡ ÀÇÇØ »ý±ä´Ù. ºÎ¸ðµéÀÌ 3¼¼ ÀÌÇÏ Æ¯È÷ 1¼¼ ÀÌÇÏÀÇ À¯¾Æ¸¦ ¹«ºÐº°ÇÏ°Ô ¶§¸®°Å³ª ±âŸ ¹æ¹ýÀ¸·Î ÇдëÇÔÀ¸·Î½á ÀϾ´Â ½Åü Áõ»ó. ¹Ì±¹ÀÇ ¼Ò¾Æ°ú ÀÇ»ç H. ÄÍÇÁ µîÀÌ ¹Ì±¹ Àü¿ª¿¡ °ÉÃÄ Á¶»çÇÏ¿´À¸¸ç, 1962³âÀÌ·¡ ¼±Áø Á¦±¹¿¡ ³Î¸® ¾Ë·ÁÁø Çö»óÀÌ´Ù. ÁÖ·Î, ¨ç ÇÇÇÏ ÃâÇ÷, Àý»ó, È­»ó µîÀÇ ÇǺΠÁõ¼¼, ¨è Àü½ÅÀÇ °ñÀý, Å»±¸, ¨é µÎ°³³» ÃâÇ÷À̳ª °æ¸·ÇÏÇ÷Á¾, ¨ê Àå±â ÆÄ¿­ ¹× ³»ÃâÇ÷ µî º¹ºÎÀÇ ¼Õ»ó, ¨ë ¼ºÀå ¹ß´Þ ÀåÇØ µîÀ» º¼ ¼ö ÀÖ´Ù. À̰ÍÀº ¿À´Ã³¯ÀÇ ¼±Áø Á¦±¹ÀÇ ±Þ¼ÓÇÑ °¡Á¤ ºØ±« Çö»ó°ú °ü·ÃÇÏ¿© ÀϾ´Â Áõ¼¼ÀÌ´Ù. ºÎºÎ°£ÀÇ °¥µîÀÌ ±Ø½ÉÇØÁö¸é À̵éÀº ¼­·Î °£ÆíÇÏ°Ô Çì¾îÁ®¾ß ÇÑ´Ù°í »ý°¢Çϰí À̶§ ¾î¸°¾ÆÀ̵éÀÌ Àå¾Ö¹°À̶ó ¹Ï°Ô µÇ¾î ¾Æ¹« ÁË ¾ø´Â ¾ÆÀ̵éÀ» ¸¶±¸ ÆøÇàÇÏ´Â µîÀÇ ÇдëÇàÀ§°¡ ³ªÅ¸³­´Ù. Çд븦 °¡ÇÏ´Â ºÎ¸ðµéÀº Á¤¼­ÀûÀ¸·Î ¹Ì¼÷ÇÑ È÷½ºÅ׸® ¼º°ÝÀÚ, ¼ºÀû ºÒ°¨Áõ, °ø°Ý¼º ¼º°ÝÀÚ, ¾ËÄÚ¿Ã Áßµ¶ÀÚ, ¸Á»óÇüÀÇ Á¤½ÅºÐ¿­Áõ ȯÀÚ µî¿¡¼­ º¼ ¼ö ÀÖ´Ù. À̶§ Çд븦 ¹ÞÀº ¾ÆÀ̵éÀº Á¤½Å ¹ß´Þ Àå¾ÖÁõ, ¹ÝÇ×Àû ¼º°Ý, °íÁýÀÌ ¼¾ Ç×¹®±âÀû °íÂøÁõ µîÀÇ Æ¯Â¡À» ³ªÅ¸³½´Ù. ÀÌ·¯ÇÑ Çö»óÀº Çѱ¹ÀÇ »çȸ ¹®È­¿¡¼­´Â ¾ÆÁ÷ Èñ±ÍÇÏÁö¸¸ ±Ù´ëÈ­, ÇÙ°¡Á·È­, ¿©±ÇÀÇ ½ÅÀå, ¾ËÄÚ¿Ã Àα¸ÀÇ Áõ°¡, »çȸÀû ½ºÆ®·¹½º ¿äÀÎÀÇ Áõ´ë·Î Á¡Á¡ Áõ°¡µÈ´Ù.
  • Bechet syndrome
    º£Ã¼Æ® ÁõÈıº
    º£Ã¼Æ® ÁõÈıºÀº ¹Ýº¹µÇ´Â ±¸°­ ¹× ¼º±âÀÇ ±Ë¾ç°ú ´« ¹× ÇǺΠµîÀ» ħ¹üÇÏ´Â ¿©·¯ ±â°ü¿¡ ¿À´Â ÁúȯÀÌ´Ù. ¾ÆÁ÷±îÁö È®½ÇÇÑ ¿øÀÎÀº ¸ð¸£Áö¸¸ Ç÷°ü¿°ÀÌ ÁÖµÈ º´¸® ¼Ò°ßÀ̰í ÀÚ°¡ Ç×ü°¡ 50%¿¡¼­ ÃâÇöÇÏ´Â °ÍÀ¸·Î º¸¾Æ¼­ ÀÚ°¡¸é¿ª ÁúȯÀÇ Çϳª¶ó°í »ý°¢Çϰí ÀÖ´Ù. Áõ»óÀÇ Á¤µµ´Â ½Ã°£ÀÌ °¡¸é ´úÇØÁö°í ½ÉÇÑ ÇÕº´ÁõÀÌ ¾ø´Â ÇÑ ¼ö¸í°ú´Â °ü°è°¡ ¾ø´Ù. ±×·¯³ª Ä¡·á´Â Ưº°ÇÑ °ÍÀÌ ¾ø°í ´ëÁõÀûÀÌ°í °æÇèÀûÀÎ Ä¡·á¸¦ ÇϰԵǾî Áõ»ó¿¡ µû¶ó¼­
  • Behcet's syndrome
    º£Ã¼Æ® ÁõÈıº, Behcet ÁõÈıº
    ±¸°­, ´«, ¼º±âÀÇ º´¼Ò°¡ Ư¡ÀΠƯ¹ß¼º Áúȯ. ´«¿¡¼­ º¼ ¼ö ÀÖ´Â ¼Ò°ßÀº Æ÷µµ¸·¿°, ¸Á¸·¿° ¹× °á¸·¿°À̰í, ¼º±â¿¡ ³ªÅ¸³ª´Â ¼Ò°ßÀº ´ë°³°¡ ÇÇºÎ¿Í Á¡¸·ÀÇ ±Ë¾çÀ̸ç, ±¸°­¿¡ ³ªÅ¸³ª´Â ¼Ò°ßÀº À¯»ç ¾ÆÇÁŸ¼º ±Ë¾çÀÌ´Ù. Áø´ÜÀº ÀÓ»ó ¼Ò°ß¿¡ ±Ù°ÅÇÑ´Ù. Ä¡·á¿¡´Â Àü½Å¼º ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å Åõ¿©¸¦ ÀÌ¿ë. À¯ÀüÀû ¿ä¼Ò°¡ ÀÖ´Ù°í º¸°íµÇ°í ÀÖ´Ù.
  • big heart syndrome
    °Å½É ÁõÈıº
  • black cardiac syndrome
    Èæ½ÉÀå ÁõÈıº
  • Boerhaave syndrome
    ºÆ¸£ÇϺ£ ÁõÈıº
    ±¸Åä·Î ÀÎÇØ ½ÄµµÀÇ ÀÚ¿¬ÀûÀÎ ÆÄ¿­À» ¸»Çϴµ¥ µ¿Åë°ú ¹ß¿­À» ¼ö¹ÝÇÑ °ß°©°ñ¾È ȤÀº Èä°ñÇÏ µ¿ÅëÀ» È£¼ÒÇÏ°í ¼îÅ© »óŰ¡ ¹ß»ýÇϱ⵵ ÇÑ´Ù. ±¤¹üÀ§ÇÑ ±«»ç¼º Á¾°Ýµ¿¿°Àº ÆíÃø ȤÀº ¾çÃø¼º ³óÈäÀ» ÃÊ·¡½Ã۱⵵ ÇÏ¿© 24~48½Ã°£³» »ç¸Á½Ã۱⵵ ÇÑ´Ù. ÀÓ»ó Áõ»óÀº ÈäºÎ X-¼± »çÁø»ó °æºÎ Á¶Á÷¸é°ú Á¾°Ýµ¿³» °ø±â°¡ ³ªÅ¸³ª°í Á¾°Ýµ¿ »óÀÌ È®´ëµÇ°í Á¾°Ýµ¿¿¡ ¾×¸é»ó°ú µå¹°°Ô ½É³¶°ú ÅëÇØ ½É³¶³» ¾×¸é»óÀÌ º¸À̱⵵ ÇÑ´Ù. ½Äµµ Á¶¿µ¼úµµ Áø´ÜÀÌ °¡´ÉÇÏ¸é °¡´ÉÇÑ ÇÑ ºü¸¥ Áø´Ü°ú Ä¡·á¸¸ÀÌ È¯ÀÚÀÇ »ýÁ¸À²À» ³ôÀÏ ¼ö ÀÖ´Ù.
  • bottle mouse syndrome
    ¿ìÀ¯º´ ¿ì½Ä
    Àå½Ã°£ ¿ìÀ¯¸¦ ¹°°í ÀÖ´Â À¯¾Æ¿¡ È£¹ß, ÇÏ¾Ç ÀýÄ¡¿¡´Â ¿ì½ÄÁõÀÌ ¾ø´Ù.
  • brain death syndrome
    ³ú»ç ÁõÈıº
  • brain stem syndrome
    ³ú°£ ÁõÈıº
  • Briquets syndrome
    ºê¸®ÄÉ ÁõÈıº
    µ¿ÀǾî=ataxia syndrome. ºê¸®ÄÉ ¿îµ¿ ½ÇÁ¶ ÁõÈıº.
  • brittle hair syndrome
    Ãë¾à ¸ð¹ß ÁõÈıº
  • bronze baby syndrome
    ûµ¿»ö ¾Æ±â ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
deficiency, glucose-6-phosphate dehydrogenase Deficiency of G6PD is the commonest disease-causing enzyme defect in humans affecting an estimated 400 million people. The G6PD gene is on the X chromosome. Males with the enzyme deficiency develop anaemia due to breakup of their red blood cells when they are exposed to oxidant drugs such as the antimalarial primaquine, the sulfonamide antibiotics or sulfones, naphthalene moth balls, or fava beans.
(12 Dec 1998)
deficiency, iron Deficiency of iron results in anaemia because iron is necessary to make haemoglobin, the key molecule in red blood cells responsible for the transport of oxygen. In iron deficiency anaemia, the red cells are unusally small (microcytic) and pale (hypochromic). Characteristic features of iron deficiency anaemia in children include failure to thrive (grow) and increased infections. The treatment of iron deficiency anaemia , whether it be in children or adults, is with iron and iron-containing foods. Food sources of iron include meat, poultry, eggs, vegetables and cereals (especially those fortified with iron). According to the National Academy of Sciences, the Recommended Dietary Allowances of iron are 15 milligrams per day for women and 10 milligrams per day for men.
(12 Dec 1998)
deficiency, lactase Lack of the enzyme lactase resulting in failure to digest lactose in milk (lactose intolerance).
(12 Dec 1998)
deficiency, magnesium Can occur due to inadequate intake or impaired intestinal absorption of magnesium. Low magnesium (hypomagnesaemia) is often associated with low calcium (hypocalcaemia) and potassium (hypokalaemia) levels. Deficiency of magnesium causes increased irritability of the nervous system with tetany (spasms of the hands and feet, muscular twitching and cramps, spasm of the larynx, etc.). According to the National Academy of Sciences, the Recommended Dietary Allowances of magnesium are 420milligrams per day for men and 320 milligrams per day for women. The upperlimit of magnesium as supplements is 350 milligrams daily, in addition to the magnesium from food and water.
(12 Dec 1998)
deficiency mutant Mutant with a nutritional requirement not present in the wild type organism.
Synonym: defective organism, deficiency mutant.
(05 Mar 2000)
deficiency, protein c Protein C is a protein in plasma that enters into the cascade of biochemical events leading to the formation of a clot. Deficiency of protein C results in thrombotic (clotting) disease.
(12 Dec 1998)
deficiency, selenium Deficiency of the essential mineral selenium causes Keshan disease, a fatal form of cardiomyopathy (disease of the heart muscle) first observed in Keshan province in China and since found elsewhere. According to the National Academy of Sciences, the Recommended Dietary Allowances of selenium are 70 milligrams per day for men and 55 milligrams per day for women. Food sources of selenium include seafoods, some meats such as kidney and liver, and some grains and seeds.
(12 Dec 1998)
deficiency symptom Manifestation of a lack, in varying degrees, of some substance (e.g., hormone, enzyme, vitamin) necessary for normal structure and/or function of an organism.
(05 Mar 2000)
deficiency, zinc Deficiency of zinc is associated with short stature, anaemia, increased pigmentation of skin (hyperpigmentation), enlarged liver and spleen (hepatosplenomegaly), impaired gonadal function (hypogonadism), impaired wound healing, and immune deficiency. (For a genetic disorder that impairs zinc uptake, please see Acrodermatitis enteropathica). According to the National Academy of Sciences, the Recommended Dietary Allowances of zinc are 12 milligrams per day for women and 10 milligrams per day for men. Food sources of zinc include meat including liver, eggs, seafood, nuts and cereal.
(12 Dec 1998)
disaccharidase deficiency A digestive disorder caused by the body being unable to produce enough disaccharidase, an enzyme responsible for breaking down carbohydrates in the small intestine. This may cause symptoms such as intestinal gas and diarrhoea.
(09 Oct 1997)
IgA deficiency A dysgammaglobulinaemia characterised by a deficiency of IgA.
(12 Dec 1998)
IgG deficiency A dysgammaglobulinaemia characterised by a deficiency of IgG.
(12 Dec 1998)
immune deficiency Impaired ability of the bodys defence mechanisms to combat infections by bacteria, viruses and fungi.
(13 Nov 1997)
immune deficiency diseases Those diseases in which immune reactions are suppressed or reduced. Reasons may include congenital absence of B and/or T lymphocytes or viral killing of helper lymphocytes (see HIV).
(18 Nov 1997)
immunoglobulin G subclass deficiency A rare inherited disorder in which there are reduced levels of one or more IgG subclasses resulting from defective heavy chain genes or an abnormality in the regulation of immunoglobulin isotype switching.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
ÅëÇÕ°Ë»ö ¿Ï·á